Expression and characterization of a serine protease that preferentially cleaves insulin-like growth factor binding protein-5

Journal of Cellular Biochemistry

Volumn 94, Issue 3, 2005, Pages 470-484

  Hou, J ^a   Clemmons, David R ^b   Smeekens, S ^a  

^a Axys Pharmaceuticals Inc   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Insulin like growth factor I; Proteolysis

Indexed keywords

3,4 DICHLOROISOCOUMARIN; CELL SURFACE RECEPTOR; EDETIC ACID; GROWTH FACTOR; LEUPEPTIN; SERINE PROTEINASE; SERINE PROTEINASE INHIBITOR; SOMATOMEDIN BINDING PROTEIN 5; TOSYLLYSYL CHLOROMETHYL KETONE; TOSYLPHENYLALANYL CHLOROMETHYL KETONE; COMPLEMENTARY DNA; INSULIN LIKE GROWTH FACTOR BINDING PROTEINASE, HUMAN; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINASE, HUMAN;

AMINO TERMINAL SEQUENCE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; ENZYME BINDING; ENZYME PURIFICATION; HUMAN; HUMAN CELL; INSECT CELL; INSULIN METABOLISM; KIDNEY CELL CULTURE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FAMILY; RECEPTOR BINDING; CHEMISTRY; GENETICS; HYDROLYSIS; METABOLISM; MOLECULAR CLONING; MOLECULAR GENETICS; NORTHERN BLOTTING; NUCLEOTIDE SEQUENCE; SEQUENCE HOMOLOGY; WESTERN BLOTTING;

INSECTA;

BASE SEQUENCE; BLOTTING, NORTHERN; BLOTTING, WESTERN; CLONING, MOLECULAR; DNA, COMPLEMENTARY; HUMANS; HYDROLYSIS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 5; MOLECULAR SEQUENCE DATA; SEQUENCE HOMOLOGY, AMINO ACID; SERINE ENDOPEPTIDASES;

EID: 23044491228     PISSN: 07302312     EISSN: None     Source Type: Journal    
DOI: 10.1002/jcb.20328     Document Type: Article

References (38)

1. Arai T, Clarke JB, Parker A, Busby WH, Jr., Nam TJ, Clemmons DR. 1996. Substitution of specific amino acids in insulin-like growth factor-binding protein-5 alters heparin binding and its change in affinity for IGF-I in response to heparin. J Biol Chem 271:6099-6106.
2. Busby WH, Nam TJ, Moralez A, Smith C, Jennings M, Clemmons DR. 2000. The complement component C1s is the protease that accounts for cleavage of insulin-like growth factor binding protein-5 in fibroblast medium. J Biol Chem 275:37638-37644.
3. Campbell PG, Andress DL. 1997. Plasmin degradation of insulin-like growth factor binding protein-5 (IGFBP-5): Regulation by IGFBP-5 (201-218). Endocrinol Metab 273:E996-E1004.
4. Campbell PG, Durham SK, Suwanichkul A, Hayes JD, Powell DR. 1998. Plasminogen binds the heparin binding domain of insulin-like growth factor binding protein-3. Am J Physiol 275:E321-E331.
5. Chandrasekhar YA, Van Dessel HJ, Fauser BC, Giudice LC. 1995. Estrogen-but not androgen-dominant human ovarian follicular fluid contains an insulin-like growth factor binding protein-4 protease. J Clin Endocrinol Metab 80:2734-2739.
6. Chernausek SD, Smith CE, Duffin KL, Busby WH, Wright G, Clemmons DR. 1995. Proteolytic cleavage of insulin like growth factor binding protein-4 (IGFBP-4). J Biol Chem 270:11377-11382.
7. Conover CA, Durham SK, Zapf J, Masiarz FR, Kiefer MC. 1995a. (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-binding protein-4 mutants. J Biol Chem 270:(9):4395-4400.
8. Conover CA, Durham SK, Zapf J, Masiarz FR, Kiefer MC. 1995b. Cleavage analysis of insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis and expression of protease-resistant IGF-bindings protein-4 mutants. J Biol Chem 270:4395-4400.
9. Fineberg AP, Vogelstein B. 1983. A technique for labelling DNA restriction endonuclease fragments to high specific activity. Anal Biochem 137:266-272.
10. Fowlkes J, Serra DM, Rosenberg CK, Thrailkill KM. 1995. Insulin-like growth factor binding protein-3 (IGFBP-3) functions as an IGF-reversible inhibitor of IGFBP-4 proteolysis. J Biol Chem 270:27481-27488.
11. Giudice LC, Farrell EM, Pham H, Lamson G, Rosenfeld RG. 1992. Insulin-like growth factor binding proteins in maternal serum throughout gestation and in the puerperium: Effects of a pregnancy-associated serum protease activity. J Clin Endo Metab 71:806-816.
12. Gray CW, Ward RV, Karran E, Truconi S, Rowles A, Viglienghi D, Southan C, Barton A, Fantom KG, West A, Savopoulos J, Hassan NJ, Clinkenbeard H, Hanning C, Amegadzie B, Davis JB, Dingwall C, Livi GP, Creasy CL. 2000. Characterization of human HtrA1: A novel serine protease involved in the mammalian cellular stress response. Eur J Biochem 267:5699-5710.
13. Hakeda Y, Kawaguchi H, Hurley M, Pilbeam CC, Abreu C, Linkhart TA, Mohan S, Kumegawa M, Raisz LG. 1996. Intact insulin-like growth factor binding protein-5 (IGFBP-5) associates with bone matrix and soluble fragments of IGFBP-5 accumulated in culture medium of neonatal mouse calvariae by parathyroid hormone and prostaglandin E2-IGFBP-5 treatment. J Cell Physiol 166:370-379.
14. Han VKM, D'Ercole AJ, Lund PK. 1987. Cellular location of somatomedin (insulin-like growth factor) messenger RNA in the human fetus. Science 236:193-197.
15. Hossenlopp P, Segovia B, Lassare C, Roghani M, Bredon M, Binoux M. 1990. Enzymatic evidence of degradation of insulin-like growth factor binding protein in 150 k complex during pregnancy. J Clin Endocrinol Metab 71:797-805.
16. Hu SI, Carozza M, Klein M, Pascale N, Luk D, Crawl RM, Herault H. 1998. An evolutionary conserved serine protease identified as a differentially expressed gene product in osteoarthritic cartilage. J Biol Chem 273:34406-34412.
17. Hwa V, Oh Y, Rosenfield RG. 1999. The insulin-like growth factor binding protein (IGFBP) superfamily. Endocrine Rev 20:761-787.
18. Imai Y, Busby WH, Smith CE, Clark JB, Horvitz GD, Rees C, Clemmons DR. 1997. Protease resistant form of insulin-like growth factor binding protein-5 is an inhibitor of insulin-like growth factor-I actions in porcine smooth muscle cells in culture. J Clin Invest 100:2596-2605.
19. Jones JI, Clemmons DR. 1995. Insulin like growth factor and their binding proteins: Biologic actions. Endocrine Rev 16:3-34.
20. Kanzaki S, Hilliker S, Baylink DJ, Mohan S. 1994. Evidence that human bone cells in culture product insulin-like growth factor-binding protein-4 and -5 proteases. Endocrinology 134:383-392.
21. Lawrence JB, Qxuig C, Overgaard MT, Sottrup-Jensen L, Gleich GJ, Harp LG, Yates JR, Conover CA. 1999. The insulin-like growth factor (IGF) dependent IGF binding protein-4 protease secreted by human fibroblasts is pregnancy-associated plasma protein-A. Proc Natl Acad Sci USA 96:3149-3153.
22. Lipinska B, Zylicz M, Georgopoulos C. 1990. The HtrA (DegP) protein, essential for Escherichia coli survival at high temperatures, is an endopeptidase. J Bacteriol 172:1791-1797.
23. Loechel F, Fox JW, Murphy G, Albrechtsen R, Wewer U. 2000. Adam 12-S cleaves IGFBP-3 and IGFBP-5 and is inhibited by TIMP-3. Biochm Biophys Res Comm 278:511-515.
24. Maile LA, Gill ZP, Perks CM, Holly JM. 1999. The role of cell surface attachment and proteolysis in the insulin-like growth factor (IGF) independent effects of IGF binding protein-3 on apoptosis in breast cancer cells. Endocrinology 140:4040-4045.
25. Matsumoto T, Gargosky SE, Kelley K, Rosenfeld RG. 1996. Characterization of an insulin-like growth factor binding protein-5 protease produced by rat articular chondrocytes and a neuroblastoma cell line. Growth Reg 6:185-190.
26. Miyakoshi N, Richman C, Kasukawa Y, Linkhart TA, Baylink DJ, Mohan S. 2001. Evidence that IGF-binding protein-5 functions as a growth factor. J Clin Invest 107:73-81.
27. Mohan S, Thompson GR, Amaar YG, Hathaway G, Tschesche H, Baylink DJ. 2002. Adam-9 is an insulin-like growth factor binding protein-5 protease produced and secreted by human osteoblasts. Biochemistry 41:15394-15403.
28. Nam TJ, Busby WH, Jr., Clemmons DR. 1996. Characterization and determination of the relative abundance of two types of IGFBP-5 proteases that are secreted by human fibroblasts. Endocrinology 137:5530-5536.
29. Olney RC, Tsuchiya K, Wilson DM, Mohtai M, Maloney WJ, Schurman DJ, Smith RL. 1996. Chrondrocytes from osteoarthritic cartilage have increased expression of insulin-like growth factor I (IGF-I) and IGF-binding protein-3 (IGFBP-3) and -5, but no IGF-II or IGFBP-4. J Clin Endocrinol Metab 81:1096-1103.
30. Overgaard MT, Boldt HB, Laursen LS, Sottrup-Jensen L, Conover CA, Oxvig C. 2001. Pregnancy associated plasma protein-A2 (PAPP-A2), a novel insulin-like growth factor-binding protein-5 proteinase. J Biol Chem 276:21849-21853.
31. Rehault S, Monget P, Mazerbourg A, Tremblay R, Gutman N, Gauthier F, Moreau T. 2001. Insulin-like growth factor binding proteins (IGFBPs) as potential physiological substrates for human kallikreins hK2 and hK3. Eur J Biochem 268:2960-2968.
32. Schuller AG, Groffen C, Van Neck JW, Zwarthhoff EC, Drop SL. 1994. cDNA cloning and mRNA expression of the six mouse insulin-like growth factor binding proteins. Mol Cell Endocrinol 104:56-66.
33. Shi Z, Yu W, Loch L, Wewer UM, Murphy LJ. 2000. Adam 12, a distintegrin metalloprotease, interacts with insulin-like growth factor binding protein-3. J Biol Chem 275:574-580.
34. Shimasaki S, Shimonaka M, Zhang HP, Ling N. 1991. Identification of five different insulin-like growth factor binding proteins (IGFBPs) from adult rat serum and molecular cloning of a novel IGFBP in rat and human. J Biol Chem 266:10646-10653.
35. Song H, Shand JH, Beattie J, Flint DJ, Allan GJ. 2001. The carboxy-terminal domain of IGF-binding protein-5 inhibits heparin binding to a site in the central domain. J Mol Endocrinol 26:229-239.
36. Standker L, Wobst P, Mark S, Forssmann WG. 1998. Isolation and characterization of circulating 12-kDa C-terminal fragments of human insulin-like growth factor binding protein-5. FEBS Lett 441:281-286.
37. Zheng B, Clarke JB, Busby WH, Duan C, Clemmons DR. 1998. Insulin-like growth factor-binding protein-5 is cleaved by physiologic concentrations of thrombin. Endocrinology 139:1708-1714.
38. Zumbrunn J, Trueb B. 1996. Primary structure of a putative serine protease for IGF binding proteins. FEBS Lett 398:187-192.